A marker's capacity to predict risk of a disease depends on disease prevalence in the target population and its classification accuracy, i.e. its ability to discriminate diseased subjects from non-diseased subjects. The latter is often considered an intrinsic property of the marker; it is independent of disease prevalence and hence more likely to be similar across populations than risk prediction measures. In this paper, we are interested in evaluating the population-specific performance of a risk prediction marker in terms of positive predictive value (PPV) and negative predictive value (NPV) at given thresholds, when samples are available from the target population as well as from another population. A default strategy is to estimate...
textabstractBackground: New markers hold the promise of improving risk prediction for individual pat...
Abstract Background New markers hold the promise of improving risk prediction for individual patient...
Peer reviewed: TrueOBJECTIVE: To clarify the performance of polygenic risk scores in population scre...
A marker\u27s capacity to predict risk of a disease depends on disease prevalence in the target popu...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/86830/1/j.1467-9876.2011.00761.x.pdfhtt...
There are two popular statistical approaches to biomarker evaluation. One models the risk of disease...
There are two popular statistical approaches to biomarker evaluation. One models the risk of disease...
There are two popular statistical approaches to biomarker evaluation. One models the risk of disea...
The performance of a well-calibrated risk model for a binary disease outcome can be characterized by...
The predictiveness curve shows the population distribution of risk endowed by a marker or risk predi...
Consider a continuous marker for predicting a binary outcome. For example, serum concentration of pr...
Thesis (Ph.D.)--University of Washington, 2019Risk markers are often used to help make clinical deci...
We present the most comprehensive comparison to date of the predictive benefit of genetics in additi...
We present the most comprehensive comparison to date of the predictive benefit of genetics in additi...
The performance of a well calibrated risk model, Risk(Y)=P(D=1|Y), can be characterized by the popul...
textabstractBackground: New markers hold the promise of improving risk prediction for individual pat...
Abstract Background New markers hold the promise of improving risk prediction for individual patient...
Peer reviewed: TrueOBJECTIVE: To clarify the performance of polygenic risk scores in population scre...
A marker\u27s capacity to predict risk of a disease depends on disease prevalence in the target popu...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/86830/1/j.1467-9876.2011.00761.x.pdfhtt...
There are two popular statistical approaches to biomarker evaluation. One models the risk of disease...
There are two popular statistical approaches to biomarker evaluation. One models the risk of disease...
There are two popular statistical approaches to biomarker evaluation. One models the risk of disea...
The performance of a well-calibrated risk model for a binary disease outcome can be characterized by...
The predictiveness curve shows the population distribution of risk endowed by a marker or risk predi...
Consider a continuous marker for predicting a binary outcome. For example, serum concentration of pr...
Thesis (Ph.D.)--University of Washington, 2019Risk markers are often used to help make clinical deci...
We present the most comprehensive comparison to date of the predictive benefit of genetics in additi...
We present the most comprehensive comparison to date of the predictive benefit of genetics in additi...
The performance of a well calibrated risk model, Risk(Y)=P(D=1|Y), can be characterized by the popul...
textabstractBackground: New markers hold the promise of improving risk prediction for individual pat...
Abstract Background New markers hold the promise of improving risk prediction for individual patient...
Peer reviewed: TrueOBJECTIVE: To clarify the performance of polygenic risk scores in population scre...